Abbott’s Freestyle Libre 2 Gains Medicare Coverage
FreeStyle Libre 2 is the only integrated continuous glucose monitoring system that continuously measures the user's blood glucose without fingersticks.
You may also be interested in...
Abbott’s 3Q $8.9Bn Sales Beat Wall Street Consensus, Medtech Sales Up 3.4%
Abbott reported strong sales for diagnostics and devices in the third quarter and raised its full-year EPS guidance to $3.55 per share.
AdvaMed White Paper Advises Systemic Medicare Coverage For Digital Technology
The medtech industry advocacy group issued a white paper on best methods for Medicare coverage of telehealth, remote patient monitoring and other digital technology.
Abbott Surprises Analysts With CE Mark For Freestyle Libre 3
The new continuous glucose sensor is the smallest and thinnest in the world, according to Abbott.